Jagson Pal & Co.

Jagsonpal Pharmaceuticals is a prominent Indian pharmaceutical company specializing in the development and commercialization of products within women's health and orthopedics. Established in 1964, the company has built a strong reputation with market-leading brands like Methergin and Doxinate, which are essential in maternal care. In 2022, the company underwent a significant leadership transition following a majority stake acquisition by Infinity Holdings. Jagsonpal operates state-of-the-art manufacturing facilities and maintains an extensive distribution network across India. The company is publicly listed on both the National Stock Exchange and the Bombay Stock Exchange. Its strategic focus remains on expanding its branded generic portfolio and strengthening its presence in the domestic healthcare market.